1. Home
  2. WST vs QSR Comparison

WST vs QSR Comparison

Compare WST & QSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • QSR
  • Stock Information
  • Founded
  • WST 1923
  • QSR 1954
  • Country
  • WST United States
  • QSR Canada
  • Employees
  • WST N/A
  • QSR N/A
  • Industry
  • WST Medical/Dental Instruments
  • QSR
  • Sector
  • WST Health Care
  • QSR
  • Exchange
  • WST Nasdaq
  • QSR Nasdaq
  • Market Cap
  • WST 15.6B
  • QSR N/A
  • IPO Year
  • WST N/A
  • QSR 2006
  • Fundamental
  • Price
  • WST $210.79
  • QSR $69.49
  • Analyst Decision
  • WST Buy
  • QSR Buy
  • Analyst Count
  • WST 7
  • QSR 19
  • Target Price
  • WST $331.67
  • QSR $76.95
  • AVG Volume (30 Days)
  • WST 623.5K
  • QSR 4.0M
  • Earning Date
  • WST 07-24-2025
  • QSR 08-07-2025
  • Dividend Yield
  • WST 0.40%
  • QSR 3.58%
  • EPS Growth
  • WST N/A
  • QSR N/A
  • EPS
  • WST 6.37
  • QSR 2.94
  • Revenue
  • WST $2,895,800,000.00
  • QSR $8,776,000,000.00
  • Revenue This Year
  • WST $3.38
  • QSR $9.67
  • Revenue Next Year
  • WST $5.82
  • QSR $3.31
  • P/E Ratio
  • WST $33.06
  • QSR $23.58
  • Revenue Growth
  • WST N/A
  • QSR 22.38
  • 52 Week Low
  • WST $187.43
  • QSR $58.71
  • 52 Week High
  • WST $352.33
  • QSR $74.79
  • Technical
  • Relative Strength Index (RSI)
  • WST 38.17
  • QSR 59.04
  • Support Level
  • WST $219.46
  • QSR $66.44
  • Resistance Level
  • WST $226.03
  • QSR $68.78
  • Average True Range (ATR)
  • WST 6.31
  • QSR 1.19
  • MACD
  • WST -1.05
  • QSR 0.28
  • Stochastic Oscillator
  • WST 14.72
  • QSR 88.41

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: